Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$26.09 - $40.4 $633,987 - $981,720
-24,300 Reduced 82.94%
5,000 $168,000
Q1 2021

May 14, 2021

SELL
$33.06 - $56.93 $3.62 Million - $6.24 Million
-109,600 Reduced 78.91%
29,300 $1.12 Million
Q4 2020

Feb 16, 2021

BUY
$39.09 - $57.4 $5.43 Million - $7.97 Million
138,900 New
138,900 $5.81 Million
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $6.13 Million - $9.01 Million
-156,900 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$28.43 - $44.67 $2.42 Million - $3.8 Million
85,000 Added 118.22%
156,900 $6.8 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $101,877 - $263,523
8,700 Added 13.77%
71,900 $2.18 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $887,004 - $3.19 Million
-116,100 Reduced 64.75%
63,200 $862,000
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $102,136 - $139,876
6,800 Added 3.94%
179,300 $2.89 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $3.25 Million - $4.74 Million
172,500 New
172,500 $3.32 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.